Henry J. Fuchs - 11 Feb 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role: Director
Signature: /s/ Vickie Reed, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 11 Feb 2022
Net transactions value: -$935,777
Form type: 4
Filing time: 14 Feb 2022, 15:51:29 UTC
Previous filing: 18 Jan 2022
Next filing: 10 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRTX	Common Stock	Options Exercise	$123,240	+6,000	+100%	$20.54	12,021	11 Feb 2022	Direct	F1
transaction	MRTX	Common Stock	Options Exercise	$102,700	+5,000	+42%	$20.54	17,021	11 Feb 2022	Direct	F1
transaction	MRTX	Common Stock	Sale	$218,958	-2,090	-12%	$104.76	14,931	11 Feb 2022	Direct	F1, F2
transaction	MRTX	Common Stock	Sale	$920,428	-8,700	-58%	$105.80	6,231	11 Feb 2022	Direct	F1, F3
transaction	MRTX	Common Stock	Sale	$22,332	-210	-3.4%	$106.34	6,021	11 Feb 2022	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRTX	Non Qualified Stock Option (right to buy)	Options Exercise	$0	-6,000	-100%	$0.000000^*	0	11 Feb 2022	Common Stock	6,000	$20.54	Direct	F1
transaction	MRTX	Non Qualified Stock Option (right to buy)	Options Exercise	$0	-5,000	-100%	$0.000000^*	0	11 Feb 2022	Common Stock	5,000	$20.54	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021.
F2	This transaction was executed in multiple trades at prices ranging from $104.23 to $105.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $105.28 to $106.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $106.33 to $106.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.